Blood clots can be extremely hazardous to your health and can even lead to death. A device known as an inferior vena cava (IVC) filter has been developed as a way to reduce the chances of blood clots traveling to areas of the body that can result in a fatality—such as the lungs—but using these devices can present another set of risks to patients.
Numerous patients have reported suffering an IVC filter injury after the device was implanted in their body. Such injuries occur when the device breaks or migrates inside the body. Injuries that have been reported include pulmonary embolism, constant chest pain, respiratory distress, hemorrhaging, and perforation of the vessels, tissues, and organs.
These risks resulted in the U.S. Food and Drug Administration outlining a set of guidelines and warnings for the use of IVC filters, which are highlighted in an article released by Endovascular Today; however, many of those who have been harmed as the result of using IVC filters have filed lawsuits against the manufacturer of the product.
Settlements are beginning to be reached in these suits as well. Earlier this month, CR Bard—a company known for manufacturing IVC filters—reached a settlement for an undisclosed amount in damages with a Nevada man who was allegedly harmed by their product.
It can be extremely difficult to overcome the injuries that are caused by using a defective medical device. That’s why our attorneys at Fleschner, Stark, Tanoos & Newlin are hopeful settlements such as this one will bring closure to the victims who were injured.
Fleschner, Stark, Tanoos & NewlinN/a
The financial burden that often comes with a serious injury can be too much for many people to bear. Unexpected medical debt, damaged personal property, and the sudden loss of income can impact the budgets of most families. The good news is that a successful injury claim could help reduce that financial strain after a serious accident. Get in touch with a Terre Haute personal injury lawyer with Fleschner, Stark, Tanoos & Newlin to learn more.
© Fleschner, Stark, Tanoos & Newlin